摘要
To the Editor:Sleeve resection,which is a procedure to resect and reconstruct bronchial and/or pulmonary arteries,is considered a valid therapeutic approach for centrally located lung cancer.With the establishment and development of the comprehensive treatment concept,applying neoadjuvant treatment such as neoadjuvant immunotherapy against centrally located lung cancer with locally advanced staging is effective.Neoadjuvant treatment might reduce the tumor size to increase the chances of complete resection and achieve parenchyma-sparing procedures of sleeve resection.Generally,sleeve resection improves postoperative respiratory function and quality of life,and achieves lower postoperative morbidity and mortality with similar oncological outcomes to pneumonectomy after neoadjuvant treatment.
基金
supported by the Natural Science Foundation of Shandong Province(No.ZR2020MH234)